Drugs like Ozempic have transformed how we treat obesity, but a review of almost 40 studies shows it doesn't take long for ...

Stopping weight loss drugs is followed by weight regain and reversal of beneficial effects on heart and metabolic health markers such as high cholesterol and high blood pressure, finds a study ...

When patients stop taking weight-loss medications, the beneficial effects of the drugs on weight and other health issues ...

From injectables to pills: how the new Wegovy tablet will change the weight loss market forever - IN FOCUS: The launch of an ...

There's now a prescription GLP-1 pill for weight loss on the market. Here are six key things to know about it.

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk reduction.

A daily pill for weight loss has officially arrived in the U.S. On Monday, Novo Nordisk rolled out the first GLP-1 ...

Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...

Data from a comparative study found liraglutide and dulaglutide presented similar effectiveness as semaglutide in the ...

Novo Nordisk launched the first GLP-1 weight-loss pill on Monday with a pledge that manufacturing investments will enable it to avoid the type of shortages that plagued rollout of its injectable ...